Enzymatic determination of hba1c

一种溶液、糖化血红蛋白的技术,应用在微生物的测定/检验、酶、肽酶等方向,能够解决非特异性空白值信号光谱背景增加、分析信号精确分光光度测量困难等问题

Active Publication Date: 2017-02-22
DIASYS DIAGNOSTIC SYST
View PDF9 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this method poses difficulties, the autoxidation of the leuco dye leads to a non-specific blank value signal as well as increased spectral background, which leads to difficulties in accurate spectrophotometric measurement of the analytical signal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enzymatic determination of hba1c
  • Enzymatic determination of hba1c
  • Enzymatic determination of hba1c

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a method for determining the amount of glycated haemoglobin (HbA1c), in which -if required -the erythrocytes in a sample are haemolysed, the haemoglobin that is then released -if required -is contacted with a proteolytic agent and the glycated haemoglobin degradation products obtained in this way or otherwise are quantified. In order to provide such a process and reagents employable therein that has / have the property of sufficient stability of the chemical compounds that are essential to the reaction, the provision of the requisite proteolytic agent in the form of an inactivated protease is proposed, which is then only reactivated in situ. In particular embodiments of the invention, for the stabilization of the haemoglobin which is unfolded at a very low pH in the range from 1 to 3, at least one suitable stabilizer should be present in the haemolysis solution, and, in the embodiments of the invention in which a leuco dye is used in connection with the determination of the amount of HbA1c, it is proposed in accordance with the invention that the latter be stabilized with particular phosphine compounds and / or thio compounds.

Description

Enzymatic determination of HbA1c technical field The present invention relates to a method for determining the amount of glycated hemoglobin (HbA1c) in a sample, and a kit useful in the method for determining the amount of glycated hemoglobin (HbA1c) in a sample. Background technique According to the definition of IFCC (International Federation of Clinical Chemistry and Experimental Medicine), glycated hemoglobin (HbA1c) is a stable product of glucose coupled to the N-terminal valine of the beta chain of hemoglobin, and the amount of HbA1c is relative to the amount of total hemoglobin (mmol HbA1c / mol total hemoglobin) represents the average blood glucose level in the last 8 weeks before the blood sample was taken and is therefore called "long-term blood glucose". Therefore, the HbA1c value that should generally be in the range of 20 to 42 mmol / mol is an important index for the diagnosis and treatment of diabetes. Known methods of determining HbA1c are eg immunoassays suc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/72G01N21/31
CPCG01N21/31G01N33/723G01N33/725C12Y105/03C12Y304/24027G01N2333/805C12N9/6491C12Q1/37G01N33/00G01N33/72C12Q1/26G01N2333/90672G01N2333/954C12Q1/28C12Q2326/00
Inventor G·戈卡Y·渡津E·梅兹曼A·雷恩H·穆勒M·格里姆勒
Owner DIASYS DIAGNOSTIC SYST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products